CPT1A and steatosis: Thus, in accordance with these observations and other reported findings (El-Assal et al., 2004; Hong et al., 2004), we anticipated that the administration of exogenous IL-6 would ameliorate the steatosis observed in IL-6−/− mice fed a HFD by increasing AMPK activity and CPT1 expression.